Common Contracts
3 similar Grant Agreement contracts
GRANT AGREEMENTGrant Agreement • September 21st, 2023
This Agreement (“Agreement”), effective as of 1ST OCTOBER 2023, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Sjældne Diagnoser (“Organization”) (collectively, the “Parties”).
GRANT AGREEMENTGrant Agreement • December 5th, 2022
This Agreement (“Agreement”), effective as of 05 December 2022, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and Patientforeningen for Lymfekræft, Leukæmi og MDS (“Organization”) (collectively, the “Parties”).
GRANT AGREEMENTGrant Agreement • February 28th, 2022
This Agreement (“Agreement”), effective as of 28th February 2022, is entered into between Takeda Pharma A/S, “Delta Park 45, DK- 2665 Vallensbæk Strand - Denmark (Takeda”), CVR 16406899 and LyLe Patientforeningen for Lymfekræft, Leukæmi og MDS, Banetoften 26, 4700 Næstved (“Organization”) (collectively, the “Parties”).
